Arelle
Filing Index
Oruka Therapeutics, Inc.
COMPANY
10-Q
FORM
2026-05-13
FILING DATE
2026-03-31
Q1
PERIOD END
931
FACTS
SIC
2834
CIK
0000907654
Taxonomy
US GAAP 2026
SIC
2834
CIK
0000907654
Taxonomy
US GAAP 2026
Standard Concepts
276
Extended Concepts
85
24%
Extended Concepts
Errors
0
What are errors?
What are errors?
Indicate problems with an XBRL formatted filing that are sufficient grounds for SEC rejection of the XBRL portion of the filing.
Data Quality Errors
0
What are data quality errors?
What are data quality errors?
Indicate areas that may not meet the standards set by the Data Quality Committee (DQC), and may reveal areas where the XBRL can be improved.
SEC:
Filing
|
Interactive Data